Approved Study Database

Ref. No. Scientific Title Principal investigator
2025.583 Clinical features and Treatment outcomes in Paediatric probable antibody-negative autoimmune encephalitis in Hong Kong Dr. YAM Karen Kwan Ming
2011.009 A Cross-sectional Study on Specific Upper Limb Muscle Activities and Fatigue Pattern after simulated Game with Electromyography and Synchronized Video Capture for Boccia Athletes Ms Yam Kit Yee
2024.049 Review of efficacy and safety of MEK inhibitor for treatment of neurofibromatosis Type 1 (NF1)-associated plexiform neurofibroma (PN) in Hong Kong Dr. YAM Kwan Ming
任君明
2016.521 Evaluation of the association of electroencephalogram (EEG) patterns with mortality in patients with altered mental state Dr. YAM Kwan Ming
任君明
2013.563 Left ventricular mass and clinical characteristics of persistent masked hypertension in Hong Kong youth - a community cohort study Dr Yam Man Ching
2010.003 Novel care pathway for managing patients with acute urinary retention in the emergency medicine ward: a retrospective study Ms YAM Shuk Fong Estella
2010.343 Difficulties, satisfaction, and coping strategies of the family caregivers of stroke survivors Miss YAM Yim Ling
2009.167 Chinese Translation and Validation of the Walking Impairment Questionnaire in Patients with Peripheral Arterial Disease Prof. YAN Bryan
2010.595 Hong Kong Cardiovascular Health Survey: Awareness & Knowledge of Cardiovascular Risk & Cardiovascular Risk Reduction Behaviour Prof Yan Bryan
2009.041 Efficacy, Safety and Cost-Effectiveness of Drug-eluting Stents in “Real World” Hong Kong Cardiology Practice Dr. YAN Bryan
2015.538 A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696 Prof. YAN Bryan
甄秉言教授
2013.351 Effect of Heparin on Radial Artery Occlusion After Transradial Artery Catheterization for Coronary Angiography. Professor YAN Bryan
2011.053 Efficacy, Safety and cost-effectiveness of anti-proliferative treatment of coronary arteries with catheter-based delivery of fluid paclitaxel after bare-metal stenting to reduce restenosis in high-risk patients: A multicenter randomized controlled study Prof Yan Bryan
2017.695 Validation of a new non-invasive oscillometric device for capillary blood pressure measurement Dr. YAN Bryan
甄秉言
2019.571 Gaps In Awareness of Peripheral Arterial Disease in Hong Kong: A Cross Sectional Study Prof. YAN Bryan Ping Yen
甄秉言
2020.448 Rationale and Design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): A Randomized, Open-label study Prof. YAN Bryan Ping Yen
甄秉言教授
2018.393 Validation of a cuffless blood pressure device for 24-hours ambulatory blood pressure monitoring Prof. YAN Bryan Ping Yen
甄秉言
2018.442 A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome Prof. YAN Bryan Ping Yen
甄秉言
2020.080 A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients with established cardiovascular disease Prof. YAN Bryan Ping Yen
甄秉言教授
2019.004 Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease Prof. YAN Bryan Ping Yen
甄秉言教授
2018.382 ILUMIEN IV: OPTIMAL PCI OPtical Coherence Tomography (OCT) Guided Coronary Stent IMplantation Compared to Angiography: a Multicenter Randomized TriaL in PCI Prof. YAN Bryan Ping Yen
甄秉言
2020.082 A Non-randomized, Clinical Registry of the DynamX Novolimus Eluting Coronary Bioadaptor System in the Treatment of Patients with De Novo Native Coronary Artery Lesions Prof. YAN Bryan Ping Yen
甄秉言教授
2019.357 Prolonged Ambulatory Heart Rate Variability Monitoring to Predict Major Adverse Cardiac Events in High-risk Patients with Cardiovascular Diseases Prof. YAN Bryan Ping Yen
甄秉言
2019.021 Activation Pattern and Acute Hemodynamics of His and Left Bundle Pacing Prof. YAN Bryan Ping Yen
2018.214 XIENCE 28 Global Study Prof. YAN Bryan Ping Yen
甄秉言
2020.154 BIOFLOW-DAPT: BIOTRONIK – A Prospective, Randomized, Multi-center Study to Assess the SaFety of the Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for Bleeding in combination With 1-month Dual AntiPlatelet Therapy Prof. YAN Bryan Ping Yen
甄秉言
2019.346 HD Mapping Observational Study Prof. YAN Bryan Ping Yen
甄秉言
2018.299 Lipid management status of patients with ischemic stroke (IS) in Hong Kong Prof. YAN Bryan Ping Yen
2018.215 Electrical Activation Mapping Guided Cardiac Resynchronization Therapy for Nonresponders Prof. YAN Bryan Ping Yen
2018.068 A nurse-coordinated integrated care model to support decision-making and self-care in patients with atrial fibrillation: A randomized controlled trial Prof. YAN Bryan Ping Yen
2018.304 Achievement of cardiovascular risk factor goals and target levels in patients at very-high and high cardiovascular risk in Hong Kong Prof. YAN Bryan Ping Yen
甄秉言
2019.653 In-Depth Analyses of 12-lead ECG P-wave Indices Using Machine Learning to Predict Atrial Fibrillation and Cardiovascular Events Prof. YAN Bryan Ping Yen
甄秉言
2014.332 A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate DUAL antithrombotic therapy with dabigatran etexilate (110mg and 150mg b.i.d.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with non valvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting. (RE-DUAL PCI) Prof. YAN Bryan Ping Yen
2014.210 Randomized controlled trial and cost-effectiveness analysis of targeted rapid screening for atrial fibrillation using a handheld single-lead ECG device with automated diagnostics and tailored stroke prevention strategy for screen-detected patients Prof. YAN Bryan Ping Yen
2010.440 A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction Prof. YAN Bryan Ping Yen
2011.178 A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus Prof. YAN Bryan Ping Yen
2013.420 Transcatheter Renal Denervation with an over-the-wire balloon based technology for Patiemts with Resistant Hypertension Prof. YAN Bryan Ping Yen
2009.531 A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia Prof. Yan Bryan Ping Yen
2012.561 Novel Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule Prof. YAN Bryan Ping Yen
2013.658 A PHASE 3 DOUNLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDMIA AT RISK OF CARDIOVASCULAR EVENTS Prof. YAN Bryan Ping Yen
2013.586 GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation (Phase II/III) Prof. YAN Bryan Ping Yen
2011.534 Type D personality in patients contemplating coronary revascularization Prof. YAN Bryan Ping Yen
2024.339 Investigations of cardiotoxicity in cancer survivors Prof. YAN Bryan Ping Yen
2024.212 Retrospective Database Study for Treatment Patterns of Lipid-lowering Therapy in Patients with Hypercholesterolemia or Mixed Dyslipidemia in Hong Kong and South Korea (READY Study) Prof. YAN Bryan Ping Yen
甄秉言
2024.251 BIOTRONIK – Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (Freesolve) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A randomized controlled trial Prof. YAN Bryan Ping Yen
甄秉言
2025.443 Risk Factors for Blood Pressure Variability in Patients with Cardiovascular Disease: a Longitudinal Telemonitoring Cohort Study Prof. YAN Bryan Ping Yen
甄秉言
2024.156 A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia Prof. YAN Bryan Ping Yen
甄秉言
2024.152 Rationale and design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial Prof. YAN Bryan Ping Yen
甄秉言
2025.650 A randomized, double-blind, placebo-controlled study to evaluate efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes: Victorion – RIDES Prof. YAN Bryan Ping Yen
甄秉言
2023.577 Switching Sildenafil to Riociguat in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) Prof. YAN Bryan Ping Yen

Page 269 of 289.